Dechert advises Archimed on majority investment in Stago Group

Dechert represented ARCHIMED in connection with its acquisition of a majority stake in the Stago Group; the Caisse (formerly the Caisse de dépôt et placement du Québec) invested alongside ARCHIMED as a minority investor. The transaction entails ARCHIMED, a leading international private equity firm specializing in healthcare industries, taking a majority equity interest in the Stago Group, one of the world’s leading diagnostic companies and a specialist in hemostasis. The Caisse joins the deal as a minority investor alongside ARCHIMED. Dechert represented ARCHIMED with a team composed by: Transactional: Alain Decombe (partner); Vianney Toulouse, Yona Elfassi and Anaïs Fritzinger (associates). Merger control: Mélanie Thill-Tayara and Marion Provost (partners); Dieynaba Kane, Charles Sauvage and Victor Sampaio (associates). Healthcare regulatory and foreign investment control: Sophie Pelé (partner); Margaux Lasseigne (associate). Financing: Privat Vigand (partner); Chloé Lebret (associate). Tax and structuring: Sabina Comis (partner); Etienne Bimbeau and Pierre-Emmanuel Floc’h (associates). Employment law: Thibault Meiers (national partner). Intellectual property: Noah Leibowitz and Tom Rayski (partners); Frank Hwang (associate).

Dechert advises Archimed on majority investment in Stago Group

Read the full story